Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 177Lu-NeoB |
Synonyms | |
Therapy Description |
177Lu-NeoB is a radioconjugate comprising the radionuclide Lutetium-177 linked to the GRPR-antagonist NeoB (NeoBOMB1), which delivers radiation to GRPR-expressing tumor cells, potentially resulting in inhibition of tumor growth (PMID: 37640941, PMID: 27609789). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
177Lu-NeoB | lutetium neoB|177Lu-NeoBOMB1|Lutetium 177-NeoB | 177Lu-NeoB is a radioconjugate comprising the radionuclide Lutetium-177 linked to the GRPR-antagonist NeoB (NeoBOMB1), which delivers radiation to GRPR-expressing tumor cells, potentially resulting in inhibition of tumor growth (PMID: 37640941, PMID: 27609789). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|